Emmanuel J Favaloro/LinkedIn
Jan 17, 2026, 04:58
Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
Emmanuel J Favaloro, Lead Scientist of Sydney Centres for Thrombosis and Haemostasis, shared on LinkedIn:
“A Review of Desmopressin Use in Bleeding Disorders. Nearly 5000 article views in only 6 months. Aiming for 10,000 by it’s one year anniversary.
Free to download from here .”
Title: A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Sep 17, 2026, 16:30Daria Camilli: Empowering Bleeding Disorder Advocacy Through Health Economics
-
Sep 17, 2026, 16:17Mehran Ghasemzadeh: Platelet NK Cell Crosstalk in Advanced Coronary Artery Disease
-
Sep 17, 2026, 16:16Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
-
Sep 17, 2026, 15:46Heghine Khachatryan: Clinical Context at the Core of Thrombosis and Thrombophilia Management
-
Sep 17, 2026, 15:33Alexandros Makis: When Microcytic Anemia Has an Inherited Cause
-
Sep 17, 2026, 15:22α2-Antiplasmin Inhibition and the Future of Thrombolysis
-
Sep 17, 2026, 15:20Fatma M. Attia: Expanding the Evidence Base for Therapeutic Plasma Exchange Across Multiple Indications
-
Sep 17, 2026, 15:19Conan McIlwrath: The Haemophilia Society Engages With IBCA
-
Sep 17, 2026, 15:06Eleftheria Hatzimichael: A Contemporary Diagnostic Approach to Inherited Microcytic Anemias